MBRX - Moleculin Biotech Inc. (MBRX) Q1 2024 Earnings Call Transcript
2024-05-13 11:44:02 ET
Moleculin Biotech, Inc. [MBRX]
Q1 2024 Earnings Conference Call
May 13, 2024, 8:30 a.m. ET
Company Participants
Walter Klemp - Chairman and CEO
Jonathan Foster - EVP and CFO
Paul Waymack - Senior CMO
Jenene Thomas - IR
Conference Call Participants
Jonathan Aschoff - Roth MKM
Chad Yahn - Maxim Group
Vernon Bernardino - H.C. Wainwright
Presentation
Operator
Hello, and welcome to the Moleculin Biotech first quarter 2024 quarterly update conference call and webcast. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to turn the call over to your host, Jenene Thomas, Investor Relations. Please go ahead, Jenene.
Jenene Thomas
Thank you, Darrell. Good morning and welcome, everyone. At this time, I would like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations, or future projections. These are forward-looking statements and involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the safe harbor provisions of the federal securities laws and are based on Moleculin’s current expectations, and actual results could differ materially. As a result, you should not place undue reliance on any forward-looking statements. Some of the factors that could cause actual results to differ materially from these contemplated by such forward-looking statements, are discussed in the periodic reports Moleculin files with the Securities and Exchange Commission. These documents are available in the investor section of the company's website and on the Securities and Exchange Commission's website. We encourage you to review these documents carefully. ...
Moleculin Biotech, Inc. (MBRX) Q1 2024 Earnings Call Transcript